drugset / Trial / NCT01252160

Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage

NCT01252160

Phase 4 Completed 306 enrolled Astellas Pharma Inc
NaSingle-groupOpen-labelTreatment

Summary

In this study all patients will be treated with the same medicine, the QUTENZA patch. Subjects will receive up to 6 QUTENZA patch applications over 12 months.

Timeline

Start
2010-10-28
Primary completion
2013-09-26
Completion
2013-09-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule Topical